Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

Last updated: April 3, 2025
Sponsor: Baim Institute for Clinical Research
Overall Status: Active - Recruiting

Phase

N/A

Condition

Atherosclerosis

Thrombosis

Coronary Artery Disease

Treatment

Intravascular Lithotripsy

Cutting Balloon

Clinical Study ID

NCT06089135
BBC22
  • Ages > 21
  • All Genders

Study Summary

The Short-Cut trial is a prospective, investigator-initiated, multicenter, randomized controlled trial that is designed to compare the efficacy of cutting balloon angioplasty vs. intravascular lithotripsy prior to drug-eluting stent implantation in patients with moderate to severely calcified coronary arteries.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Subject is > 21 years old 2. Subject with an indication for PCI for thetreatment of a) stable coronary artery disease; b) unstable angina; or c)NSTEMI with evidence of down-trending biomarkers 3. Subject is willing and ableto provide informed written consent Angiographic Inclusion Criteria

  2. The target lesion is a de novo native coronary lesion

  3. The target vessel is a native coronary artery with either:

  4. A stenosis > 70%; or,

  5. A stenosis > 50% and <70% with evidence of ischemia via either positivestress test, FFR value < 0.80 or RFR/iFR/DFR value < 0.89

  6. The reference diameter of the target vessel is > 2.5mm and < 4.0 mm at thelesion site

  7. The target lesion has evidence of significant calcium at the lesion sitedefined either as,

  8. The presence of radiopacities involving both sides of the arterial wall > 5mm and involving the target lesion on angiography

  9. the presence of > 270o arc of superficial calcium on intravascular imagingwith a length > 5mm or the presence of 360o arc of superficial calcium

Exclusion

Exclusion Criteria:

  1. Patient is pregnant

  2. Patient is actively participating in another clinical trial

  3. Known LVEF < 25%

  4. Ongoing Non-STEMI with rising biomarkers

  5. Cardiogenic shock or requirement for mechanical/pharmacologic hemodynamicsupport

  6. Planned use in the randomized lesion of a bare metal stent or non-stenttreatment only

  7. Patient has a known allergy to contrast which cannot be adequately pre-treated

  8. Patient has a history of bleeding or coagulopathy and is unable to receiveblood transfusion if needed

  9. Patient presents with STEMI

  10. Patient is unable to tolerate dual anti-platelet therapy

  11. Patient has suffered a recent cerebrovascular event (stroke/TIA) within last 30daysAngiographic Exclusion Criteria

  12. Presence of large thrombus in the target vessel

  13. Inability to pass coronary guidewire across the lesion

  14. The target vessel has excessive tortuosity (Defined as presence of 2+ bends > 90o or 3+ bends > 75o) or other anatomic considerations that precludesintravascular imaging

  15. The target lesion is within a coronary artery bypass graft

  16. The target lesion involves a bifurcation lesion in which either a 2-stentstrategy is planned or both branches are planned for calcium modification

  17. Coronary artery disease that requires surgical revascularization

  18. Angiographic or imaging evidence of dissection in the target vessel prior torandomization

  19. Investigator feels there is not equipoise regarding the treatment strategy

Study Design

Total Participants: 410
Treatment Group(s): 2
Primary Treatment: Intravascular Lithotripsy
Phase:
Study Start date:
December 31, 2023
Estimated Completion Date:
December 30, 2025

Study Description

The trial will be composed of two cohorts:

  • Patients treated with up-front rotational atherectomy

  • Patients in whom atherectomy is not planned

Randomization to either cutting balloon angioplasty or intravascular lithotripsy will occur as follows in the 2 cohorts:

  • After rotational atherectomy is safely completed In the rotational atherectomy arm

  • After safe and successful wire crossing in patients in whom atherectomy is not planned.

The trial is designed to demonstrate non-inferiority between cutting balloon angioplasty and intravascular lithotripsy in each cohort with regards to the primary endpoint of post-procedural stent area as measured by intravascular imaging at the site of maximal calcification.

Connect with a study center

  • UAB Structural Heart and Valve Clinic

    Birmingham, Alabama 35233
    United States

    Active - Recruiting

  • Banner Health

    Phoenix, Arizona 85012
    United States

    Active - Recruiting

  • Honor Health

    Scottsdale, Arizona 13400
    United States

    Active - Recruiting

  • UCSF Cardiology

    San Francisco, California 94117
    United States

    Active - Recruiting

  • Yale School of Medicine

    New Haven, Connecticut 06510
    United States

    Active - Recruiting

  • Saint Luke's

    Overland Park, Kansas 66207
    United States

    Active - Recruiting

  • Maine Medical Center

    Portland, Maine 04102
    United States

    Active - Recruiting

  • Beth Israel Deaconess Medcial Center

    Boston, Massachusetts 02215
    United States

    Active - Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts 02115
    United States

    Active - Recruiting

  • Henry Ford Health

    Detroit, Michigan 48202
    United States

    Active - Recruiting

  • Capital Cardiology

    Albany, New York 12211
    United States

    Active - Recruiting

  • Columbia Cardiology

    New York, New York 10032
    United States

    Active - Recruiting

  • Columbia University Medical Center/ NewYork Presbyterian Hospital

    New York, New York 10032
    United States

    Site Not Available

  • Christ Hospital

    Cincinnati, Ohio 45219
    United States

    Active - Recruiting

  • UPMC

    Pittsburgh, Pennsylvania 15213
    United States

    Active - Recruiting

  • Wellspan York Hospital

    York, Pennsylvania 17403
    United States

    Active - Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee 37232
    United States

    Active - Recruiting

  • Baylor Heart and Vascular Hospital

    Dallas, Texas 75226
    United States

    Active - Recruiting

  • Houston Methodist

    Houston, Texas 77030
    United States

    Active - Recruiting

  • Baylor Scott and White Health

    Plano, Texas 75024
    United States

    Active - Recruiting

  • UVA Heart and Vascular Center

    Charlottesville, Virginia 22903
    United States

    Active - Recruiting

  • University of Washington

    Seattle, Washington 98195
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.